To assess whether the oncogenic role of DCAF7 extends beyond LIHC, we focused on breast cancer, in which DCAF7 is highly expressed (Figure 1) and explored its biological effects in the BT549 cell line. Here, DCAF7 is linked to breast carcinoma.